BioArctic receives new patent in the US for blood-brain barrier transport technology
Stockholm, November 14, 2022 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US Patent and Trademark Office (USPTO) has granted BioArctic a new platform patent for a technology for transporting biopharmaceuticals across the blood-brain barrier. The patent, which is part of the company’s Brain Transporter patent portfolio, will take effect on November 15, 2022, and expire in 2037.The blood-brain barrier protects the brain from foreign substances by restricting the passage of these substances into the brain. The patented technology (US patent no. 11,498,974) has been